肝硬化:现状及西医与中医治疗选择
本文综述肝硬化非药物与药物治疗进展,指出西医疗效不确定而中医(汤剂、中成药、针灸)在逆转肝硬化及改善预后方面有显著效果,中西医结合治疗具优势,值得进一步研究与临床推广。
要点
- 中医汤剂、中成药及针灸在肝硬化逆转和改善预后方面显示显著效果。
- 中西医结合治疗肝硬化具有相当优势,值得进一步研究与临床推广。
- 基于研究制定标准化治疗方案具有重要临床意义。
核心结论
- 中医干预(汤剂、中成药、针灸)在肝硬化逆转和改善预后方面有显著效果。
- 中西医结合治疗肝硬化具有相当优势,值得进一步研究和临床推广。
研究设计与样本
- 综述,探讨肝硬化治疗的非药物与药物模式进展。
主要发现
- 西医治疗肝硬化疗效不确定,中医具有明显优势。
- 中医汤剂、中成药及针灸在肝硬化逆转和改善预后方面显示显著效果。
- 中西医结合治疗肝硬化具有相当优势。
临床怎么用
- 可考虑中医汤剂、中成药及针灸用于肝硬化逆转和改善预后。
- 可探索中西医结合方案治疗肝硬化,但需进一步研究支持临床推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Liver cirrhosis arises from liver fibrosis and necroinflammation caused by various mechanisms of hepatic injury. It is a prevalent condition in clinical practice characterized by hepatocellular dysfunction, portal hypertension, and associated complications. Despite its common occurrence, the etiology and pathogenesis of liver cirrhosis remain incompletely understood, posing a significant health threat. Effective prevention of its onset and progression is paramount in medical research. Symptoms often include discomfort in the liver area, while complications such as sarcopenia, hepatic encephalopathy, ascites, upper gastrointestinal bleeding, and infection can arise. While the efficacy of Western medicine in treating liver cirrhosis is uncertain, Chinese medicine offers distinct advantages. This review explores advancements in liver cirrhosis treatment encompassing non-pharmacological and pharmacological modalities. Chinese medicine interventions, including Chinese medicine decoctions, Chinese patent medicines, and acupuncture, exhibit notable efficacy in cirrhosis reversal and offer improved prognoses. Nowadays, the combination of Chinese and Western medicine in the treatment of liver cirrhosis also has considerable advantages, which is worthy of further research and clinical promotion. Standardized treatment protocols based on these findings hold significant clinical implications.
引用
- Zheng S, Xue C, Li S, et al. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Front Pharmacol. 2024. PMID: 39081955. doi:10.3389/fphar.2024.1381476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。